Essex Capital Corporation

Active

Updated: Apr 2, 2026 ·

Financial History

Total Raised

N/A

Valuation

N/A

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Feb 25, 2015	Neos Therapeutics	$20.6M Other Equity	—	Burrill Life Sciences Capital Fund III, CAC, Crabtree Partners, Delaware Street Capital, Presidio Partners
Jun 10, 2011	Revance Therapeutics	$45.0M Other Equity	Jonathan Tunnicliffe	CNF Investments, Pac-Link Ventures, Palo Alto Investors, Shepherd Ventures, Technology Partners, Vivo Ventures

Total Raised

N/A

Valuation

N/A